Healthcare - Biotechnology - NASDAQ - US
$ 2.3
-6.5 %
$ 289 M
Market Cap
-4.11
P/E
INCOME STATEMENT
0
REVENUE
-76.2 M
OPERATING INCOME
-63.7 M
NET INCOME
EFFICIENCY
Earnings Waterfall
Nautilus Biotechnology, Inc.
| Revenue | 0 |
| Cost Of Revenue | 5.7 M |
| Gross Profit | -5.7 M |
| Operating Expenses | 76.2 M |
| Operating Income | -76.2 M |
| Other Expenses | -12.5 M |
| Net Income | -63.7 M |
Income Statement
Millions
| Dec-2023 | Dec-2022 | Dec-2021 | Dec-2020 | Dec-2019 | Dec-2018 | |
|---|---|---|---|---|---|---|
| REVENUE | ||||||
| Revenue | 0 | 0 | 0 | 0 | 0 | 0 |
| GROSS PROFIT | ||||||
| Cost Of Revenue | 5.7 | 3.4 | 2.8 | 2.3 | 0 | 0 |
| Gross Profit | (5.7) | (3.4) | (2.8) | (2.3) | 0 | 0 |
| OPERATING INCOME | ||||||
| Operating Expenses | 76.2 | 63.6 | 50.5 | 15.7 | 9.62 K | 111.7 |
| Selling, General and Administrative Expenses | 28.9 | 25.9 | 21.1 | 3.3 | 1.62 K | 111.7 |
| Research and Development Expenses | 47.3 | 37.7 | 29.4 | 12.4 | 8.49 K | 0 |
| Operating Income | (76.2) | (63.6) | (50.5) | (15.7) | 10.1 K | (111.7) |
| PRE-TAX INCOME | ||||||
| Interest Income Expense | 0 | 5.8 | 0 | 0 | 0 | 0 |
| Total Other Income | 12.5 | 5.7 | 0.2 | 0.1 | (9.6) | 738.3 |
| Pre-Tax Income | (63.7) | (57.9) | (50.3) | (15.6) | 9.62 K | 626.6 |
| NET INCOME | ||||||
| Tax Provision | 0 | 5.8 | 2.6 | 2.1 | (0.2) | 738.1 |
| Net Income | (63.7) | (63.7) | (50.3) | (15.6) | 9.62 K | 626.6 |
| EPS | 0.51 | 0.51 | 0.6 | 0.52 | 0.0013 | 87.2 |